Skip to content
Home/Companies/Healthcare/iNova
iNova

iNova

Healthcare·Australia·Exited 2021
Entry
–
Hold
–
Exit
2021

Who owns iNova?

iNova was owned by The Carlyle Group through Carlyle Europe Technology Partners IV (2019 vintage), exited via Secondary.

Buyer identity available on Pro.

Hand-verified · updated 2026-04-21

The Carlyle Group
Investor
The Carlyle Group
Carlyle Europe Technology Partners IV · 2019 · Growth

Key facts

HQAustralia
SectorHealthcare
Websiteinovapharma.com.au
Exit Type
Secondary
Buyer
MOIC
–
Exit Year
2021

More from Carlyle Europe Technology Partners IV

Other portfolio companies in the same fund.

1E
1E
Exited 2025
SoftwareUK
to
Calastone
Calastone
Active
FinancialsUK
Codorníu Raventós
Codorníu Raventós
Active
ConsumerSpain
Comdata
Exited 2022
Business ServicesUS
to
Compana Pet Brands
Compana Pet Brands
Active
ConsumerUS
CSS AG
Active
SoftwareGermany

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
A Place for Mom
A Place for Mom
Active
Silver LakeUS
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Adagene
Active
General AtlanticChina
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Track iNova

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on iNova.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue